Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review.
Department of Neurology and Stroke Centre, Bichat University Hospital, 46, rue Henri Huchard, 75018 Paris, France.
Elena
E
Meseguer
Julien
J
Labreuche
Jeam Marc
JM
Olivot
Halim
H
Abboud
Philippa C
PC
Lavallee
Olivier
O
Simon
Lucie
L
Cabrejo
Amaya
A
Echeverria
Isabelle F
IF
Klein
Mikael
M
Mazighi
Pierre
P
Amarenco
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose / Q000378:metabolism; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000401:mortality; D002544:Cerebral Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005602:France; D006801:Humans; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination / Q000187:drug effects; D016017:Odds Ratio; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012042:Registries; D012307:Risk Factors; D016019:Survival Analysis; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D001786:Blood Glucose; D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator